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constituents of the Bhutanese medicinal plant Pleurospermum amabile
Abstract
With the objective of determining safety and verifying the traditional uses of the Bhutanese medicinal
plant, Pleurospermum amabile Craib & W. W. Smith, we investigated its crude extracts and the isolated
phytochemicals for their biological activities. Four phenylpropanoids [(E)-isomyristicin (1), (E)-isoapiol (2
), methyl eugenol (3) and (E)-isoelemicin (4)] and six furanocoumarins [psoralen (5), bergapten (6),
isoimperatorin (7), isopimpinellin (8 ), oxypeucedanin hydrate (9) and oxypeucedanin methanolate (10 )]
were isolated from this plant. Among the test samples, compound 10 showed weak antibacterial activity
against Bacillus subtilis and best antimalarial activity against the Plasmodium falciparum strains, TM4/
8.2 (chloroquine and antifolate sensitive) and K1CB1 (multidrug resistant). None of the test samples
showed cytotoxicity. This study generated scientific data that support the traditional medical uses of the
plant.
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With the objective of determining safety and verifying the traditional uses of the Bhutanese medicinal plant, Pleurospermum amabile Craib & W. W. Smith,
we investigated its crude extracts and the isolated phytochemicals for their biological activities. Four phenylpropanoids [(E)-isomyristicin (1), (E)-isoapiol (2),
methyl eugenol (3) and (E)-isoelemicin (4)] and six furanocoumarins [psoralen (5), bergapten (6), isoimperatorin (7), isopimpinellin (8), oxypeucedanin
hydrate (9) and oxypeucedanin methanolate (10)] were isolated from this plant. Among the test samples, compound 10 showed weak antibacterial activity
against Bacillus subtilis and best antimalarial activity against the Plasmodium falciparum strains, TM4/8.2 (chloroquine and antifolate sensitive) and K1CB1
(multidrug resistant). None of the test samples showed cytotoxicity. This study generated scientific data that support the traditional medical uses of the plant.
Keywords: Pleurospermum amabile, Bhutanese medicinal plant, Antibacterial, Antimalarial, Furanocoumarins, Phenylpropanoids.

The Pleurospermum belong to the family Apiaceae (Umbelliferae)
and about 30-50 species are reported from Eastern Europe, north
Asia and the Himalayan region [1a-b]. Phytochemicals including
essential oils, coumarins, flavonoids, terpenoids, saponins, steroids,
fatty acids, esters, glycosides and triterpene saponins were reported
from the few species that were studied [2a-b]. Pharmacologically,
the crude extracts, essential oils and the phytochemicals were
reported to possess various therapeutic activities including,
anticancer, anti-inflammatory, antimalarial, anti-trypanosomal,
antibacterial, analgesic, apoptosis inducing, and inhibition of
hyperlipidemia and hypercholesterolemia [1a, 2a, 3a-b].
Traditionally, most of these species have been used as vegetables,
medicinal plants and herbal perfumes. For example, in Korea, the
aerial portion of P. kamtschaticum is used as an edible mountain
vegetable and for treating colds, arthritis, atherosclerosis and
impotence [4]. The root of P. angelicoides is used in Himalayan and
Chinese folk medicines for treating dysentery and as an antipyretic
and a diaphoretic agent [5]. Similarly, P. densiflorum is used by the
Kumaon Himalayan people (Indian) as one of the best herbal
perfumes in the region and is known for its long lasting pleasant
smell [6].

ur
OH
Figure 1: Struct es of compounds (1-10) isolated from the Me
extract of P.
amabile.

In Bhutan, out of the eight reported species of Pleurospermum [7],
P. amabile Craib & W. W. Smith is used in Bhutanese traditional
medicine (BTM) for treating dyspepsia, poisoning and fever, and is
also often used as a substitute for musk, which is obtained from the
Himalayan musk deer (endangered and prohibited) [8]. P. amabile

We have previously studied the essential oil component of this plant
and found interesting bioactivity [1a]. This interesting preliminary
finding encouraged us to further investigate the chemical
components of the methanol extract of this plant for the first time.
The MeOH extract was sequentially fractionated with n-hexane,
petroleum spirit, CH2Cl2, CHCl3, EtOAc and n-butanol to obtain
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grows to a height of 15-50 cm, with a stout root and a solitary stem
in open scrub, alpine turf and the semi-stable screes of the high
altitude Himalayan mountains (3950 to 4700 masl) of Bhutan [7,8].

their respective fractionated extracts. These extracts were purified
repeatedly using silica gel column chromatography and preparative
thin layer chromatography (PTLC). Finally, four phenylpropanoids
and six furanocoumarins were identified by comparing the
LR-ESI-MS, LR-EI-MS, 1H NMR and 13C NMR spectroscopic data
of the isolated compounds with those of the relevant literature, as
detailed in the experimental section. The compounds are (Figure 1):
(E)-isomyristicin (1), (E)-isoapiol (2), methyl eugenol (3), (E)isoelemicin (4), psoralen (5), bergapten (6) (major compound of a
plant), isoimperatorin (7), isopimpinellin (8), oxypeucedanin
hydrate (9) and oxypeucedanin methanolate (10).

Table 1: Antibacterial, antimalarial and cytotoxicity activities of crude extracts and
compounds 1-10 isolated from P. amabile.
Antibacterial
(MIZ in mm)
B. subtilis
a
CH2 Cl2 extract
14
CHCl3 extract a
6
Pet. spirit extract*
–
Ethyl acetate extract
–
n-Butanol extract
–
Essential oil (EO)b
5
5
1b
6
2b
Samples

Antiplasmodial
(IC50 in μg/mL)
TM4/8.2
K1CB1
12.1 ± 0.4
10.9 ± 2.3
7.8 ± 1.8
7.3 ± 2.6
27.6 ± 4.3
37.9 ± 14.1
24.3 ± 3.2
25.2 ± 6.5
>100
>100
79.0 ±4.6
72.3 ± 2.1
>100
>100
52.9 ± 2.9
69.9 ± 2.0

Cytotoxicity
(IC50 in μg/mL)
Vero
KB
>25
>25
>25
>25
>50
>50
>100
>100
>100
>100
>100
>100
>100
>100
>100
>100

–
3
>17.8
>17.8
>17.8
>17.8
–
>20
>20
>20
>20
4b
–
>18.6
16.4 ± 0.3
>18.6
>18.6
5
–
>10.8
>10.8
>10.8
>10.8
6
–
19.1 ± 0.9
18.5 ± 0.7
>27.0
>27.0
7
–
19.5 ± 2.3
15.6 ± 2.5
>24.6
>24.6
8
–
24.9 ± 2.0
18.7 ± 2.3
>30.4
>30.4
9
10
9
7.4 ± 1.3
6.7 ± 1.1
>31.8
>31.8
8
Amoxicillinc
Chloroquined
0.01
0.09
0.009
0.81
Cycloguanild
Pyrimethamined
0.02
7.70
Ellipticinee
0.09
e
Doxorubicin
0.56
a
b
c
Original activity taken from [9]. Original activity taken from [1a]. Positive controls for
d
e
antibacterial activity. Positive controls for antiplasmodial activity. Positive controls for
cytotoxicity activity. *Petroleum spirit extract. –: Not Active.

We investigated these compounds (1-10) and various crude extracts
for their antimicrobial, antimalarial and cytotoxicity activities.
Some biological activities reported earlier by us [1a, 9] for this plant
are reproduced in Table 1 for easy comparisons. The antimicrobial
assay was performed using seven bacterial strains and one fungal
strain in a modified Agar Well Diffusion method (AWD) and the
broth microdilution methods in 96 well plates that determined the
minimum inhibitory concentrations (MIC). Unlike the previously
reported activity of crude extracts and compounds 1-2 [1a] (Table
1), the crude petroleum spirit, EtOAc and n-BuOH extracts and the
pure compounds 3-8 studied here did not show any interesting
antimicrobial activities. However, compound 10 showed weak
activity against the Gram-positive bacterium, Bacillus subtilis with
a minimum inhibition zone (MIZ) of 9 mm and a MIC value of 125
µg/mL (Table 1). Compound 6 (bergapten), isolated from
Heracleum maximum, was reported to be moderately active against
Mycobacterium tuberculosis with a MIC value of 200 µg/mL and
an IC50 value of 27 µg/mL [10].

adenocarcinoma (MK-1), human uterus carcinoma (HeLa) and
murine melanoma (B16F10) cells [11]. Compounds 5 (against HL60 and K562) and 7 (against L1210, HL-60, K562, B16F10) were
also reported to exhibit moderate cytotoxicity against various tumor
cell lines [12].

Among the three crude extracts (petroleum spirit, EtOAc and
n-BuOH extracts) and seven pure compounds (3 and 5-10) studied
here, the petroleum spirit and EtOAc crude extracts, and
compounds 7-10 exhibited moderate to significant antiplasmodial
activity against a wild type chloroquine and antifolate sensitive
strain, TM4/8.2 and the multidrug resistant strain, K1CB1 of
Plasmodium falciparum (Table 1). The petroleum spirit and EtOAc
crude extracts showed moderate activities with IC50 values in the
range of 24.3-37.9 µg/mL. The varying activities of the crude
extracts and the EO described in Table 1 (including previous data,
but inactive fractions not shown) suggested that the more potent
chemical components are present in the CH2Cl2 and CHCl3 extracts
when compared with the other extracts.

In summary, the petroleum spirit and EtOAc crude extracts
exhibited moderate antiplasmodial activity against a wild type
chloroquine and antifolate sensitive strain, TM4/8.2 and the
multidrug resistant strain, K1CB1 of Plasmodium falciparum.
These activities were lower than the CHCl3 and CH2Cl2 which we
reported earlier. Focusing our isolation of phytochemicals on these
active fractions (Table 1), ten compounds (1-10) were isolated with
isomyristicin (1) and bergapten (6) as the major constituents.
Among the ten compounds that were bio-assayed, compound 10
exhibited the highest activity against the same P. falciparum strains
mentioned above. These biological activities were found to be in
conformity with the traditional uses of P. amabile in BTM
formulations and, therefore, provide scientific insight to this plant.

Out of ten compounds (1-10) isolated from these active extracts,
oxypeucedanin methanolate (10) isolated from the CHCl3 extract
exhibited the highest and the most significant antimalarial activity
against both P. falciparum strains, TM4/8.2 and K1CB1 with IC50
values of 7.4 µg/mL and 6.7 µg/mL, respectively. Such activities
were similar to that of its parent crude CHCl3 extracts, but threefold
better than its closely related compound 9 (oxypeucedanin hydrate)
(Table 1). Compounds 7-9 also showed weak to moderate
antiplasmodial activity with IC50 values in a similar range of 15.624.9 µg/mL. Compound 5 showed selectivity against the K1CB1
strain with an IC50 value of 16.4 µg/mL, but it was not active
against the TM4/8.2 strain. Interestingly, two major compounds of
this plant, (E)-isomyristicin (1) and bergapten (6), did not exhibit
any biological activity.

Experimental

While none of the test samples that we studied showed any major
cytotoxicity or anticancer activity against human oral carcinoma KB
cells, compounds 7 and 9-10 that were isolated from different plant
species have been reported to possess antiproliferative activity by
inhibiting the growth of nude mouse-transplantable human gastric
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Plant materials: The aerial components of P. amabile Craib & W.
W. Smith (voucher number 29) were collected from Lingzhi (4200
m above sea level) in July 2009 and a herbarium specimen was
deposited at Manjong Sorig Pharmaceuticals, Ministry of Health,
Thimphu, Bhutan. The dried plant material (2 kg) was extracted
with methanol (190 g of MeOH obtained).
Isolation and identification of compounds from the MeOH
extract: The equipment used, and the isolation and characterization
techniques carried out were as described by us previously [13a-b].
The known compounds were identified through MS library
matching techniques (NIST and NISTREP mass spectra library) and
then confirmed through comparison of their MS and NMR spectra
(500 MHz, CDCl3) with those reported and discussed as follows.
The MeOH extract was dissolved in MeOH/water (1:9) and
fractionated first with n-hexane and petroleum spirit to obtain their
respective extracts. The remaining aqueous portion was acidified
with HCl (5%) and fractionated with CH2Cl2 to obtain the acidic

extract. The aqueous portion was again basified with NH4OH to pH
9-12 and then fractionated with CHCl3 to obtain a basic CHCl3
extract followed by EtOAc and n-butanol giving EtOAc and BuOH
extracts, respectively. The remaining aqueous layer was dried to
obtain the H2O extract. Each of these extracts (50-100 mg) was used
for determining their biological activities. The initial purification
was focused on the most active CHCl3 extract (13.3 g) using silica
gel CC and a gradient eluent solvent system of MeOH-CH2Cl2
(500 mL, v/v ratios 0:100, 5:95, 10:90, 15:85, 50:50), which yielded
13 fractions, CHCl3-F1 to CHCl3-F13). Separation of fraction
CHCl3-5 using PTLC plates with CH2Cl2 (100%) as an isocratic
solvent system, yielded compounds 1-4, which were identified
as (E)-isomyristicin (1), (E)-isoapiol (2), methyl eugenol (3) and
(E)-isoelemicin (4). Fraction CHCl3-F7 was separated using the
same method and solvent system as above and furnished psoralen
(5), bergapten (6) (as major compound) and isoimperatorin (7).
Fraction CHCl3-F10, upon separation using preparative TLC plates
with MeOH-CHCl3 (1:19) as the solvent system, yielded
isopimpinellin (8), oxypeucedanin hydrate (9) and oxypeucedanin
methanolate (10). From the petroleum spirit, CH2Cl2, and EtOAc
extracts, the same compounds were obtained. The n-hexane,
n-BuOH and H2O extracts were not studied here.

indicated a [M+H+] peak at m/z 271, and its LR-EI-MS
fragmentation pattern matched that of isoimperatorin in the MS
library system (NIST08.LIB, Entry # 90508, CAS: 482-45-1). The
1
H NMR and 13C NMR spectroscopic data of this compound agreed
well with those of isoimperatorin reported in the literature [19a-b].
1
Isopimpinellin (8) was isolated as white solid. The EI-MS, H NMR
13
and C NMR spectroscopic data of this compound agreed well with
those of isopimpinellin reported in the literature [20].
Oxypeucedanin hydrate (9) was isolated as light yellowish needles
from MeOH/CHCl3. Its LR-ESI-MS showed a [M+H+] peak at m/z
305 and the LR-EI-MS demonstrated an ion fragmentation pattern
which matched that of oxypeucedanin hydrate in the MS library
system (NIST08.LIB, Entry # 114683, CAS: 24724-52-5). The 1H
NMR and 13C NMR spectroscopic data of this compound agreed
well with those of isopimpinellin reported in the literature [11].
Oxypeucedanin methanolate (10) was isolated as a white solid. Its
LR-ESI-MS indicated a [M+H+] peak at m/z 319, and the LR-EIMS established the ion fragmentation pattern as m/z 318 [M+], 286,
215, 202 (base peak), 185, 174, 157, 145, 118, 99, 85, 73, 59, and
51. The 1H NMR and 13C NMR spectroscopic data of this
compound agreed well with those of oxypeucedanin methanolate
reported in the literature [11].

Identification of phenylpropanoids (1-4): (E)-isomyristicin (1)
showed a [M+H+] peak at m/z 193, and an ion fragmentation pattern
that matched that of isomyristicin in the MS library system
(NIST08.LIB, Entry # 15372, CAS: 607-91-0). The 1H NMR and
13
C NMR spectroscopic data of this compound agreed well with
those reported for isomyristicin [14a-b]. (E)-isoapiol (2) was
isolated as an oil, which showed a [M+H+] peak at m/z 222 in
the LR-ESI-MS. The LR-EI-MS exhibited fragmentation ions at
m/z 222 (base peak), 207, 191, 177, 163, 149, 134, 121, 106, 91, 77,
65, 53, and 39. The 1H NMR and 13C NMR spectroscopic data of
this compound agreed well with those of isoapiol reported in the
literature [15]. Methyl eugenol (3) was isolated as colorless oil. Its
LR-ESI-MS showed a [M+H+] peak and fragmentation ions that
matched those of eugenol methyl ether in the MS library system
(NIST08s.LIB, Entry # 13416, CAS: 93-15-2). The 1H NMR
and 13C NMR spectroscopic data of this compound agreed
well with those of methyl eugenol reported in the literature [16].
(E)-isoelemicin (4) was isolated as colorless oil. Its LR-ESI-MS
showed a [M+H+] peak at m/z 209 and a [M+] peak at m/z 208. The
1
H NMR spectroscopic data of this compound agreed with those of
(E)-isoelemicin reported in the literature [14b].

Bioassay methods: The antimicrobial, antiplasmodial and
cytotoxicity tests were carried out in the same ways as we have
reported earlier [9, 13a-b]. For the antimicrobial agar well diffusion
and broth microdilution bioassay, Escherichia coli (ATCC 25922),
Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC
6538), methicillin resistant S. aureus (MRSA), (DMST 20651), S.
epidermidis (ATCC 12228), Vibrio cholerae (DMST 2873) and
Candida albicans (ATCC 10231) were used as test strains.
Amphotericin B (Sigma-Aldrich, USA) was used as a positive
control for antifungal testing against Candida albicans (not shown
in Table 1 as the samples were found to be inactive). Vancomycin
(Edicin, Slovenia) and amoxicillin (GPO, Thailand) were used as
the positive controls for antibacterial assays. The K1CB1 (a
multidrug resistant) and TM4/8.2 (a wild type chloroquine and
antifolate sensitive) strains of Plasmodium falciparum were used for
the modified microdilution radioisotope antiplasmodial bioassay.
This assay used chloroquine (Sigma-Aldrich), cycloguanil (SigmaAldrich) and pyrimethamine (Sigma-Aldrich) as positive controls.
For the sulforhodamine B (RSB) cytotoxicity assay, normal vero
cells from kidney of African green monkey, Cecopithecus aethiops
and the human oral carcinoma KB cells were used. This assay used
ellipticine (Sigma-Aldrich, USA) and doxorubicin (Sigma-Aldrich,
USA) as reference drugs. All the experiments were performed 3
times in duplicate (3x2) and DMSO (0.1%) and distilled water were
used as controls to rule out the solvent effects on the bioassay
results of the test samples.

Identification of furanocoumarins (5-10): Psoralen (5) was
isolated and recrystallized as white needles from MeOH/CHCl3. Its
LR-ESI-MS showed a [M+H+] peak at m/z 187, and the LR-EI-MS
exhibited an ion fragmentation pattern which matched that of
psoralen in the MS library system (NIST08.LIB, Entry # 34463,
CAS: 66-97-7). The 1H NMR and 13C NMR spectroscopic data of
this compound agreed well with those reported for psoralen [17].
Bergapten (6) was isolated and recrystallized as clear crystals from
MeOH/CHCl3. Its LR-ESI-MS displayed a [M+H+] peak at m/z 217,
and its LR-EI-MS matched that of bergapten in the MS library
system (NIST08.LIB, Entry # 53002, CAS: 484-20-8). The 1H
NMR and 13C NMR spectroscopic data of this compound agreed
well with those reported for bergapten [10, 18]. Isoimperatorin (7)
was isolated and recrystallized from MeOH/CHCl3. Its LR-ESI-MS
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